STOCK TITAN

[8-K] Molina Healthcare, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Molina Healthcare, Inc. filed a Form 8-K on July 7, 2025 to furnish Item 2.02 information. The company has released a press release (Exhibit 99.1) containing preliminary, unaudited financial results for the second quarter of 2025 and an update to its full-year 2025 adjusted earnings-per-share guidance. No numerical data or qualitative detail is included in the 8-K itself; investors must review the attached press release for specifics. The disclosure is being furnished—not filed—so it is not subject to Section 18 liability or automatically incorporated into other SEC filings. Apart from customary exhibit listings (Exhibit 104 Inline XBRL cover page), the filing reports no other material events, transactions, or changes.

Molina Healthcare, Inc. ha presentato un Modulo 8-K il 7 luglio 2025 per fornire informazioni relative all'Elemento 2.02. La società ha pubblicato un comunicato stampa (Allegato 99.1) contenente i risultati finanziari preliminari e non revisionati per il secondo trimestre del 2025 e un aggiornamento delle previsioni sull'utile per azione rettificato per l'intero anno 2025. Nel modulo 8-K non sono riportati dati numerici o dettagli qualitativi; gli investitori devono consultare il comunicato stampa allegato per i dettagli specifici. La comunicazione viene fornita come informazione, non come deposito, pertanto non è soggetta alla responsabilità ai sensi della Sezione 18 né viene automaticamente incorporata in altri documenti SEC. Oltre alle consuete elencazioni degli allegati (Allegato 104 Pagina di copertina Inline XBRL), la presentazione non segnala altri eventi, transazioni o cambiamenti rilevanti.

Molina Healthcare, Inc. presentó un Formulario 8-K el 7 de julio de 2025 para proporcionar información conforme al Ítem 2.02. La compañía ha emitido un comunicado de prensa (Anexo 99.1) que contiene los resultados financieros preliminares y no auditados del segundo trimestre de 2025 y una actualización de su guía ajustada de ganancias por acción para todo el año 2025. No se incluyen datos numéricos ni detalles cualitativos en el 8-K; los inversores deben revisar el comunicado adjunto para obtener detalles específicos. La divulgación se proporciona, no se presenta oficialmente, por lo que no está sujeta a la responsabilidad según la Sección 18 ni se incorpora automáticamente en otros documentos presentados ante la SEC. Aparte de las listas habituales de anexos (Anexo 104 Página de portada Inline XBRL), el documento no reporta otros eventos, transacciones o cambios materiales.

Molina Healthcare, Inc.는 2025년 7월 7일에 항목 2.02 정보를 제공하기 위해 Form 8-K를 제출했습니다. 회사는 2025년 2분기 예비 감사 전 재무 결과2025년 전체 조정 주당순이익 가이드라인 업데이트를 포함한 보도자료(첨부문서 99.1)를 발표했습니다. 8-K 문서 자체에는 수치 데이터나 정성적 세부사항이 포함되어 있지 않으므로 투자자들은 구체적인 내용을 확인하기 위해 첨부된 보도자료를 검토해야 합니다. 이 공시는 제출된 것이 아니라 제공된 것이므로 섹션 18 책임 대상이 아니며 다른 SEC 제출 문서에 자동으로 포함되지 않습니다. 일반적인 첨부 목록(첨부문서 104 Inline XBRL 표지)을 제외하고는 다른 중요한 사건, 거래 또는 변경 사항이 보고되지 않았습니다.

Molina Healthcare, Inc. a déposé un formulaire 8-K le 7 juillet 2025 afin de fournir des informations conformément à l'élément 2.02. La société a publié un communiqué de presse (Exhibit 99.1) contenant les résultats financiers préliminaires non audités du deuxième trimestre 2025 ainsi qu'une mise à jour de ses prévisions de bénéfice ajusté par action pour l'année complète 2025. Le formulaire 8-K ne contient aucune donnée chiffrée ni détail qualitatif ; les investisseurs doivent consulter le communiqué de presse joint pour obtenir les informations spécifiques. Cette communication est fournie et non déposée, elle n'est donc pas soumise à la responsabilité en vertu de la Section 18 et n'est pas automatiquement intégrée dans d'autres dépôts auprès de la SEC. Hormis les annexes habituelles (Exhibit 104 page de couverture Inline XBRL), le dépôt ne signale aucun autre événement, transaction ou changement important.

Molina Healthcare, Inc. reichte am 7. Juli 2025 ein Formular 8-K ein, um Informationen gemäß Punkt 2.02 bereitzustellen. Das Unternehmen veröffentlichte eine Pressemitteilung (Anlage 99.1) mit vorläufigen, ungeprüften Finanzergebnissen für das zweite Quartal 2025 sowie ein Update seiner bereinigten Gewinnprognose je Aktie für das Gesamtjahr 2025. Im 8-K selbst sind keine Zahlen oder qualitative Details enthalten; Investoren müssen die beigefügte Pressemitteilung für Einzelheiten einsehen. Die Offenlegung wird bereitgestellt, nicht eingereicht, und unterliegt daher nicht der Haftung gemäß Abschnitt 18 und wird nicht automatisch in andere SEC-Einreichungen aufgenommen. Abgesehen von den üblichen Anlagenverzeichnissen (Anlage 104 Inline XBRL Deckblatt) meldet die Einreichung keine weiteren wesentlichen Ereignisse, Transaktionen oder Änderungen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine 8-K furnishes press release; no numbers provided, so market impact is neutral until full details emerge.

The filing simply alerts investors that Molina has preliminary Q2 figures and revised 2025 EPS guidance, but withholds the actual metrics. Because the market cannot assess directionality—whether guidance was raised or lowered—the disclosure is informational rather than valuation-changing. Investors must wait for the press release or full earnings call to gauge performance. In short, this is a standard compliance step with minimal immediate financial impact.

TL;DR: 8-K is properly furnished under Item 2.02; content is limited and non-binding, posing negligible regulatory risk.

From a governance standpoint, Molina follows best practice by separating the furnished press release from filed reports, limiting potential liability. Absence of hard data keeps the document concise but also restricts investor insight. Unless the forthcoming press release contains material surprises, the current filing alone is unlikely to trigger notable market reaction.

Molina Healthcare, Inc. ha presentato un Modulo 8-K il 7 luglio 2025 per fornire informazioni relative all'Elemento 2.02. La società ha pubblicato un comunicato stampa (Allegato 99.1) contenente i risultati finanziari preliminari e non revisionati per il secondo trimestre del 2025 e un aggiornamento delle previsioni sull'utile per azione rettificato per l'intero anno 2025. Nel modulo 8-K non sono riportati dati numerici o dettagli qualitativi; gli investitori devono consultare il comunicato stampa allegato per i dettagli specifici. La comunicazione viene fornita come informazione, non come deposito, pertanto non è soggetta alla responsabilità ai sensi della Sezione 18 né viene automaticamente incorporata in altri documenti SEC. Oltre alle consuete elencazioni degli allegati (Allegato 104 Pagina di copertina Inline XBRL), la presentazione non segnala altri eventi, transazioni o cambiamenti rilevanti.

Molina Healthcare, Inc. presentó un Formulario 8-K el 7 de julio de 2025 para proporcionar información conforme al Ítem 2.02. La compañía ha emitido un comunicado de prensa (Anexo 99.1) que contiene los resultados financieros preliminares y no auditados del segundo trimestre de 2025 y una actualización de su guía ajustada de ganancias por acción para todo el año 2025. No se incluyen datos numéricos ni detalles cualitativos en el 8-K; los inversores deben revisar el comunicado adjunto para obtener detalles específicos. La divulgación se proporciona, no se presenta oficialmente, por lo que no está sujeta a la responsabilidad según la Sección 18 ni se incorpora automáticamente en otros documentos presentados ante la SEC. Aparte de las listas habituales de anexos (Anexo 104 Página de portada Inline XBRL), el documento no reporta otros eventos, transacciones o cambios materiales.

Molina Healthcare, Inc.는 2025년 7월 7일에 항목 2.02 정보를 제공하기 위해 Form 8-K를 제출했습니다. 회사는 2025년 2분기 예비 감사 전 재무 결과2025년 전체 조정 주당순이익 가이드라인 업데이트를 포함한 보도자료(첨부문서 99.1)를 발표했습니다. 8-K 문서 자체에는 수치 데이터나 정성적 세부사항이 포함되어 있지 않으므로 투자자들은 구체적인 내용을 확인하기 위해 첨부된 보도자료를 검토해야 합니다. 이 공시는 제출된 것이 아니라 제공된 것이므로 섹션 18 책임 대상이 아니며 다른 SEC 제출 문서에 자동으로 포함되지 않습니다. 일반적인 첨부 목록(첨부문서 104 Inline XBRL 표지)을 제외하고는 다른 중요한 사건, 거래 또는 변경 사항이 보고되지 않았습니다.

Molina Healthcare, Inc. a déposé un formulaire 8-K le 7 juillet 2025 afin de fournir des informations conformément à l'élément 2.02. La société a publié un communiqué de presse (Exhibit 99.1) contenant les résultats financiers préliminaires non audités du deuxième trimestre 2025 ainsi qu'une mise à jour de ses prévisions de bénéfice ajusté par action pour l'année complète 2025. Le formulaire 8-K ne contient aucune donnée chiffrée ni détail qualitatif ; les investisseurs doivent consulter le communiqué de presse joint pour obtenir les informations spécifiques. Cette communication est fournie et non déposée, elle n'est donc pas soumise à la responsabilité en vertu de la Section 18 et n'est pas automatiquement intégrée dans d'autres dépôts auprès de la SEC. Hormis les annexes habituelles (Exhibit 104 page de couverture Inline XBRL), le dépôt ne signale aucun autre événement, transaction ou changement important.

Molina Healthcare, Inc. reichte am 7. Juli 2025 ein Formular 8-K ein, um Informationen gemäß Punkt 2.02 bereitzustellen. Das Unternehmen veröffentlichte eine Pressemitteilung (Anlage 99.1) mit vorläufigen, ungeprüften Finanzergebnissen für das zweite Quartal 2025 sowie ein Update seiner bereinigten Gewinnprognose je Aktie für das Gesamtjahr 2025. Im 8-K selbst sind keine Zahlen oder qualitative Details enthalten; Investoren müssen die beigefügte Pressemitteilung für Einzelheiten einsehen. Die Offenlegung wird bereitgestellt, nicht eingereicht, und unterliegt daher nicht der Haftung gemäß Abschnitt 18 und wird nicht automatisch in andere SEC-Einreichungen aufgenommen. Abgesehen von den üblichen Anlagenverzeichnissen (Anlage 104 Inline XBRL Deckblatt) meldet die Einreichung keine weiteren wesentlichen Ereignisse, Transaktionen oder Änderungen.

false 0001179929 0001179929 2025-07-07 2025-07-07
 


UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 

 
FORM 8-K
 

 
Current Report
 
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): July 7, 2025
 

 
MOLINA HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
1-31719
13-4204626
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 

 
200 Oceangate, Suite 100,  Long Beach,  California
90802
(Address of principal executive offices)
(Zip Code)
 
Registrants telephone number, including area code: (562) 435-3666
 
N/A
 
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 Par Value
MOH
New York Stock Exchange
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 
 


 
 
 

 
Item 2.02.    Results of Operations and Financial Condition.
 
On July 7, 2025, Molina Healthcare, Inc. (the “Company”) issued a press release announcing certain preliminary unaudited financial results for the second quarter of 2025 and updating its full year 2025 adjusted earnings per share guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report.
 
Note: The information in this Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
 
Item 9.01.    Financial Statements and Exhibits.
 
(d)     Exhibits:
 
Exhibit No.
Description
99.1
Press release of Molina Healthcare, Inc., issued July 7, 2025.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   
MOLINA HEALTHCARE, INC.
     
Date:
July 7, 2025
By:
/s/ Jeff D. Barlow
     
Jeff D. Barlow
     
Chief Legal Officer and Secretary
 
 

FAQ

Why did Molina Healthcare (MOH) file an 8-K on July 7, 2025?

The company furnished an 8-K to announce a press release containing preliminary Q2 2025 results and updated full-year EPS guidance.

Does the Form 8-K provide specific financial figures for Q2 2025?

No. The filing references preliminary results but does not include any numerical data; those numbers are in Exhibit 99.1.

Where can investors find Molina Healthcare’s detailed Q2 2025 results?

Details are available in the press release attached as Exhibit 99.1 to the 8-K.

Is the information in this 8-K considered "filed" with the SEC?

No. The Item 2.02 disclosure is furnished, not filed, and therefore not subject to Section 18 liability.

Were any other material events disclosed in the July 7 8-K?

No additional items, transactions, or financial statement updates were reported beyond the press release reference.
Molina Hlthcare

NYSE:MOH

MOH Rankings

MOH Latest News

MOH Latest SEC Filings

MOH Stock Data

12.52B
53.51M
1.27%
99.03%
3.1%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
LONG BEACH